Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Surgery represents a fundamental component of treatment strategies in neuroendocrine neoplasms. Resection of the primary tumour, as well as locoregional and distant deposits, is currently the only modality possessing a chance of cure from neuroendocrine neoplasia disease. However, surgical intervention may also have legitimate palliative intents, such as cytoreduction of hormonally active tumour bulk that is not responsive to medical therapy and/or causes local symptoms. In some scenarios, such as in appendiceal neuroendocrine neoplasms, the adequate extent of surgery is debated. Increasingly, in advanced tumour stages, multimodal treatment approaches combining surgery with systemic targeted or liver-directed therapies to attain long-term control of disseminated disease are gaining rising attention.

Original publication

DOI

10.1016/j.coemr.2021.02.005

Type

Journal article

Journal

Current Opinion in Endocrine and Metabolic Research

Publication Date

01/06/2021

Volume

18

Pages

69 - 75